Long-term effect of sitagliptin on endothelial function in type 2 diabetes: a sub-analysis of the PROLOGUE study

The Effect of Sitagliptin on Carotid Artery Atherosclerosis in Type 2 Diabetes: The PROLOGUE Randomized Controlled Trial

(2016) Jun-ichi Oyama et al.   PLOS MEDICINE

Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus

(2016) Darren K. McGuire et al.   JAMA Cardiology

Comparison of effects of sitagliptin and voglibose on left ventricular diastolic dysfunction in patients with type 2 diabetes: results of the 3D trial

(2015) Hiroki Oe et al.   Cardiovascular Diabetology

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

(2015) Jennifer B. Green et al.   NEW ENGLAND JOURNAL OF MEDICINE

DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study

(2014) Kazufumi Nakamura et al.   Cardiovascular Diabetology

The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms

(2014) Yanmei Zeng et al.   Cardiovascular Diabetology

Rationale and design of a study to evaluate the effects of sitagliptin on atherosclerosis in patients with diabetes mellitus: PROLOGUE study

(2014) Jun-ichi Oyama et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes

(2014) Rury R Holman et al.   LANCET

Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Improves Endothelial Dysfunction in Association With Its Anti-Inflammatory Effects in Patients With Coronary Artery Disease and Uncontrolled Diabetes

(2013) Junichi Matsubara et al.   CIRCULATION JOURNAL

Dipeptidyl Peptidase‐4 Inhibitors Attenuate Endothelial Function as Evaluated by Flow‐Mediated Vasodilatation in Type 2 Diabetic Patients

(2013) Makoto Ayaori et al.   Journal of the American Heart Association

The Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Improves Vascular Endothelial Function in Type 2 Diabetes

(2012) Yoshiaki Kubota et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Pioglitazone improves endothelium-dependent vasodilation in hypertensive patients with impaired glucose tolerance in part through a decrease in oxidative stress

(2010) Takayuki Hidaka et al.   ATHEROSCLEROSIS

Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study

(2010) Toru Kato et al.   Cardiovascular Diabetology

Academic perspectives on the United States food and drug administration's guidance for industry on diabetes mellitus

(2010) Charles H. Hennekens et al.   Contemporary Clinical Trials

Endothelial Function and Oxidative Stress in Cardiovascular Diseases

(2009) Yukihito Higashi et al.   CIRCULATION JOURNAL